EXEL : Analysis & Opinions

  1. Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx ...

    December 17, 2014
    It has been a relatively quiet week with the holiday season coming up though a few companies came out with important pipeline ...
  2. Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog

    December 16, 2014
    Roche's (RHHBY) subsidiary Genentech and Exelixis announced the submission of NDA for cobimetinib/Zelboraf combination for ...
  3. Pipeline Advances at Exelixis - Analyst Blog

    January 18, 2013
    Exelixis, Inc. (EXEL) recently announced that it has received a notice from its partner, Roche Holding (RHHBY), regarding ...
  4. Dendreon's Chinese Water Torture

    November 3, 2011
    Dendreon's Provenge continues to shape up as a major disappointment.
  5. A Dull ASCO And The Usual Sell-Off

    June 7, 2011
    Investors shouldn't be spooked by the normal post-ASCO sell-off
  6. Four Healthcare Stocks On Fire

    November 18, 2009
    Fourth healthcare stocks that have brushed aside any potential adversity that could arise from future legislation for the ...
Trading Center